HuGE Literature Finder
Records
1
-
3
Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leukemia & lymphoma 2023 3 1-9. Ramia de Cap Maximiliano, Wu Leo P, Hirt Christian, Pihan German A, Patel Sanjay S, Tam Wayne, Bueso-Ramos Carlos E, Kanagal-Shamanna Rashmi, Raess Philipp W, Siddon Alexa, Narayanan Damodaran, Morgan Elizabeth A, Pinkus Geraldine S, Mason Emily F, Hsi Eric D, Rogers Heesun J, Toth Laura, Foucar Kathryn, Hurwitz Stephanie N, Bagg Adam, Rets Anton, George Tracy I, Orazi Attilio, Arber Daniel A, Hasserjian Robert P, Weinberg Olga K, |
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations. Cancer 2022 Sep . Ball Somedeb, Knepper Todd C, Deutsch Yehuda E, Samra Wassim, Watts Justin M, Bradley Terrence J, Chan Onyee, Hussaini Mohammad Omar, Zhang Ling, Sweet Kendra L, Kuykendall Andrew T, Talati Chetasi, Padron Eric, Komrokji Rami S, Lancet Jeffrey E, Sallman David |
Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia. Bratislavske lekarske listy 2018 119 (6): 366-372. Akin D F, Oner D A, Kurekci E, Akar |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: